Provided by Tiger Trade Technology Pte. Ltd.

Clearmind Medicine, Inc.

1.85
+0.02001.09%
Post-market: 1.80-0.0500-2.70%16:58 EDT
Volume:43.37K
Turnover:79.14K
Market Cap:2.75M
PE:-0.01
High:1.87
Open:1.85
Low:1.79
Close:1.83
52wk High:524.00
52wk Low:1.43
Shares:1.49M
Float Shares:1.48M
Volume Ratio:0.20
T/O Rate:2.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-175.9200
EPS(LYR):-303.4772
ROE:-114.61%
ROA:-51.35%
PB:0.24
PE(LYR):-0.01

Loading ...

Clearmind Medicine Sets USD 1 Conversion Price for USD 696,079.50 in Notes into Common Shares

Reuters
·
1 hour ago

Clearmind Medicine Starts Phase IIa CMND-100 Trial in Alcohol Use Disorder Patients

Reuters
·
Sep 01

Clearmind Reaches Key Milestone: Cmnd-100 Phase Iia NOW Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled

THOMSON REUTERS
·
Sep 01

SciSparc, Clearmind publish U.S. patent application for MDMA-PEA combination

TIPRANKS
·
Aug 24

Clearmind Medicine Says US Publishes MDMA-PEA Patent Application for PTSD Treatment

Reuters
·
Aug 24

Clearmind Advances Mdma-N-Acylethanolamines Ip for the Treatment of Ptsd Amid Rising U.S. Federal Support for Psychedelic Innovation

THOMSON REUTERS
·
Aug 24

Clearmind Advances CMND-100 into Alcohol Use Disorder Patients After Phase I/II Safety Milestone

Reuters
·
Aug 13

Clearmind Advances Cmnd-100 to Alcohol Use Disorder Patients After Achieving Primary Safety Endpoint

THOMSON REUTERS
·
Aug 13

Clearmind Medicine Announces Positive Permeation Results for Intranasal Meai Formulation

Reuters
·
Aug 11

Clearmind Medicine reports MEAI development program permeation study results

TIPRANKS
·
Aug 11

Clearmind Medicine Reports Positive Permeation Results for Intranasal MEAI Formulation Study

Reuters
·
Aug 11

Clearmind Medicine - Intranasal Meai Shows Enhanced Nasal Retention Without Compromising Permeation

THOMSON REUTERS
·
Aug 11

Clearmind Medicine reports DSMB approves advancing Phase I/II AUD study

TIPRANKS
·
Aug 06

Clearmind Advances CMND-100 Alcohol Use Disorder Trial into Patient Testing After Phase I Safety Readout

Reuters
·
Aug 06

Clearmind Reaches Key Clinical Trial Milestone as Dsmb Unanimously Clears Progression in AUD Study

THOMSON REUTERS
·
Aug 06

Clearmind Signs LOI to Buy 51% Stake in EV Wireless Charging Firm for $2.5 Million

Reuters
·
Aug 03

Clearmind Medicine Signs Letter of Intent to Acquire 51% Majority Stake in EV Wireless Charging Solutions for Automated Parking Systems Company

THOMSON REUTERS
·
Aug 03

Clearmind Medicine - to Extend $1.50 Mln Loan at 4% Interest, Repayable in Two Years

THOMSON REUTERS
·
Aug 03

Clearmind Medicine - Deal Valued at $2.50 Mln for 51% Majority Stake

THOMSON REUTERS
·
Aug 03

Psychedelic: Clearmind reports safety findings for CMND-100

TIPRANKS
·
Jul 30